- $11.87m
- -$11.39m
- $1.98m
Brief: Lipocine Inc Announces Positive Oral Brexanolone QEEG Results
Brief: Lipocine Announces Supply And Distribution Agreement With Pharmalink
Lipocine Inc reports results for the quarter ended in January - Earnings Summary
Lipocine Inc expected to post a loss of 78 cents a share - Earnings Preview
Brief: Lipocine LPCN 1154 Meets Bioequivalence With IV Brexanolone In Pivotal Study
Lipocine Inc reports results for the quarter ended in January - Earnings Summary
Lipocine Inc expected to post a loss of 68 cents a share - Earnings Preview
Brief: Lipocine Announces Completion Of Dosing In Pivotal Study Of Postpartum Depression
Brief: Lipocine Provided Notice To Cantor Of Its Election To Terminate The Controlled Equity Offerings Sales Agreement
U.S. STOCKS ON THE MOVE-Rent the Runway, Lumen Technologies, Enliven Therapeutics
U.S. STOCKS ON THE MOVE-Constellation Brands, Nike, Rocket Lab
U.S. STOCKS ON THE MOVE-DoorDash, Devon Energy, Arvinas
Lipocine up after drug improves fat-free mass in obesity patients in trial
Brief: Lipocine Announces Positive LPCN 2401 Clinical Results
Brief: Lipocine Announces Positive Week 52 Results From LPCN 1148 Phase 2 Study In Patients With Cirrhosis
Brief: Lipocine Announces First Cohort Dosed In Pivotal Study Of LPCN 1154
Brief: Lipocine Announces First Cohort Dosed In Pivotal Study Of LPCN 1154
Lipocine Inc reports results for the quarter ended in December - Earnings Summary
Lipocine Inc expected to post a loss of 47 cents a share - Earnings Preview